The Patent Finder

Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus

Evaxion Biotech A/S

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application PCT/EP2012/056069, filed Apr 3, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,085,631Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus
In force
 · High confidence
Evaxion Biotech A/SIn force
High confidence
US 9,534,022Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus
In force
 · High confidence
Evaxion Biotech A/SIn force
High confidence
US 10,034,928Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus
In force
 · High confidence
Evaxion Biotech A/SIn force
High confidence
US 10,675,340Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
In force
 · High confidence
Evaxion Biotech A/SIn force
High confidence
US 11,052,145Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
In force
 · High confidence
Evaxion Biotech A/SIn force
High confidence
Application 17/351,032Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
Abandoned
Abandoned Feb 12, 2026
Evaxion Biotech A/SAbandonedAbandoned Feb 12, 2026
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Evaxion Biotech A/S.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited